Peter J. Oates

8.5k citations

55 papers · 7.2k · 1 hit paper · h-index 32

Impact in

Clinical Biochemistry top 0.05%
- Advanced Glycation End Products research
Endocrinology, Diabetes and Metabolism top 0.5%
- Natural Antidiabetic Agents Studies

Papers in

Cell Biology 35
- Aldose Reductase and Taurine 34
Clinical Biochemistry 12
- Advanced Glycation End Products research 10

Co-authors: David A. Beebe (10 shared papers)Takeshi Nishikawa (2 shared papers)Takeshi Matsumura (2 shared papers)Michael Brownlee (2 shared papers)Ida Giardino (2 shared papers)Diane Edelstein (2 shared papers)Yasufumi Kaneda (2 shared papers)Mark A. Yorek (2 shared papers)
Journals: Diabetes (7 papers)Journal of Medicinal Chemistry (6 papers)The FASEB Journal (3 papers)The Journal of Cell Biology (3 papers)American Journal of Physiology-Heart and Circulatory Physiology (2 papers)
Partner nations: United States China United Kingdom

In The Last Decade

Peter J. Oates

55 papers receiving 6.9k citations

Peter J. Oates's Hit Papers

align trajectories log scale

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage 2000 · 3.7k citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2000 Nature

Peers

Countries citing papers authored by Peter J. Oates

Since Specialization

Citations

This map shows the geographic impact of Peter J. Oates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Oates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Oates more than expected).

Fields of papers citing papers by Peter J. Oates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Oates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Oates. The network helps show where Peter J. Oates may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter J. Oates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter J. Oates Line = papers co-authored together Peter J. Oates links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature ·Takeshi Nishikawa, Diane Edelstein, Xue Liang Du, Sho‐ichi Yamagishi, Takeshi Matsumura, Yasufumi Kaneda, Mark A. Yorek, David A. Beebe, Peter J. Oates, Hans‐Peter Hammes, Ida Giardino, Michael Brownlee Hit paper breakdown →	2000	3692
2	Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia Diabetes ·Pu Xia, Toyoshi Inoguchi, Timothy S. Kern, Ronald L. Engerman, Peter J. Oates, George Liang King	1994	376
3	Studies on the mechanism of ethanol-induced gastric damage in rats Gastroenterology ·Peter J. Oates, John P. Hakkinen	1988	328
4	Polyol pathway and diabetic peripheral neuropathy International review of neurobiology ·Peter J. Oates	2002	273
5	Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy Current Drug Targets ·Peter J. Oates	2008	211
6	Aldose reductase inhibitors: therapeutic implications for diabetic complications Expert Opinion on Investigational Drugs ·Peter J. Oates, Banavara L. Mylari	1999	174
7	Aldose Reductase Inhibition Protects Diabetic and Nondiabetic Rat Hearts from Ischemic Injury Diabetes ·Ravichandran Ramasamy, Peter J. Oates, Saul Schaefer	1997	135
8	Aldose Reductase–Deficient Mice Are Protected From Delayed Motor Nerve Conduction Velocity, Increased c-Jun NH2-Terminal Kinase Activation, Depletion of Reduced Glutathione, Increased Superoxide Accumulation, and DNA Damage Diabetes ·Eric C.M. Ho, K. S. L. Lam, Yuk Shan Chen, Johnny C.W. Yip, Meena Arvindakshan, Shin‐Ichiro Yamagishi, Soroku Yagihashi, Peter J. Oates, Craig A. Ellery, Stephen S.M. Chung, Sookja Kim Chung	2006	130
9	Central role for aldose reductase pathway in myocardial ischemic injury The FASEB Journal ·Yuying C. Hwang, Michiyo Kaneko, Soliman A. Bakr, Hui Liao, Yan Lü, Erin Rachel Lewis, Shi-Du Yan, Setsuko Ii, Mitsuo Itakura, Rui Liu, Hal A. Skopicki, Shunichi Homma, Ann Marie Schmidt, Peter J. Oates, Matthias J. Szabolcs, Ravichandran Ramasamy	2004	121
10	The Response of Antioxidant Genes to Hyperglycemia Is Abnormal in Patients With Type 1 Diabetes and Diabetic Nephropathy Diabetes ·Andrea Hodgkinson, Tracey Bartlett, Peter J. Oates, Beverley Ann Millward, Andrew G. Demaine	2003	115
11	A Selective Aldose Reductase Inhibitor of a New Structural Class Prevents or Reverses Early Retinal Abnormalities in Experimental Diabetic Retinopathy Diabetes ·Wei Qiang Sun, Peter J. Oates, James B. Coutcher, Chiara Gerhardinger, Mara Lorenzi	2006	111
12	Aldose reductase activation is a key component of myocardial response to ischemia The FASEB Journal ·Yuying C. Hwang, Sanai Sato, Jen-Yue Tsai, Shi-Du Yan, Soliman A. Bakr, Huiping Zhang, Peter J. Oates, Ravichandran Ramasamy	2001	94
13	X-Ray Crystallographic and Kinetic Studies of Human Sorbitol Dehydrogenase Structure ·Thomas A. Pauly, Jennifer L. Ekstrom, David A. Beebe, Boris A. Chrunyk, David Cunningham, Matthew C. Griffor, Ajith V. Kamath, S. Edward Lee, R. Madura, D. Mcguire, Timothy A. Subashi, David Jon Wasilko, Paul C P Watts, Banavara L. Mylari, Peter J. Oates, Paul D. Adams, Virginia L. Rath	2003	86
14	Hyperglycemia increases endothelial superoxide that impairs smooth muscle cell Na+-K+-ATPase activity American Journal of Physiology-Cell Physiology ·Sandeep Gupta, Eugene Chough, Jennifer Daley, Peter J. Oates, Keith Tornheim, Neil B. Ruderman, John F. Keaney	2002	80
15	Pyridones as glucokinase activators: Identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycle Bioorganic & Medicinal Chemistry Letters ·Jeffrey A. Pfefferkorn, Jihong Lou, Martha L. Minich, Kevin J. Filipski, Mingying He, Ru Zhou, Syed Ahsanuddin Ahmed, John W. Benbow, Angel-Guzman Perez, Meihua Tu, John Litchfield, Raman Sharma, Karen Metzler, Francis Bourbonais, Cong Huang, David A. Beebe, Peter J. Oates	2009	71
16	Aldose reductase, ocular diabetic complications and the development of topical Kinostat® Progress in Retinal and Eye Research ·Peter F. Kador, Milton Wyman, Peter J. Oates	2016	68
17	DIABETES INDUCED DECREASE IN DETRUSOR SMOOTH MUSCLE FORCE IS ASSOCIATED WITH OXIDATIVE STRESS AND OVERACTIVITY OF ALDOSE REDUCTASE The Journal of Urology ·Arun K. Changolkar, JOSEPH A. HYPOLITE, Michael E. DiSanto, Peter J. Oates, Alan J. Wein, Samuel Chacko	2005	65
18	A Highly Selective, Non-Hydantoin, Non-Carboxylic Acid Inhibitor of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran- 2-sulfonyl)-2-H-pyridazin-3-one Journal of Medicinal Chemistry ·Banavara L. Mylari, Sandra J. Armento, David A. Beebe, Edward L. Conn, James B. Coutcher, Michael S. Dina, Melissa T. O’Gorman, Michael C. Linhares, William H. Martin, Peter J. Oates, David A. Tess, Gregory J. Withbroe, William J. Zembrowski	2003	65
19	A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and Congeners Journal of Medicinal Chemistry ·Banavara L. Mylari, Sandra J. Armento, David A. Beebe, Edward L. Conn, James B. Coutcher, Michael S. Dina, Melissa T. O’Gorman, Michael C. Linhares, William H. Martin, Peter J. Oates, David A. Tess, Gregory J. Withbroe, William J. Zembrowski	2005	62
20	Aldose reductase inhibitors: Recent developments Birkhäuser Basel eBooks ·Reinhard Sarges, Peter J. Oates	1993	58

About Peter J. Oates

Peter J. Oates is a scholar working on Cell Biology, Clinical Biochemistry, Pharmacology, Pathology and Forensic Medicine and Physiology, having authored 55 papers that have together received 7.2k indexed citations. Recurring topics across this work include Aldose Reductase and Taurine (34 papers), Advanced Glycation End Products research (10 papers), Cannabis and Cannabinoid Research (9 papers), Heme Oxygenase-1 and Carbon Monoxide (9 papers), Diet, Metabolism, and Disease (6 papers), Cardiac Ischemia and Reperfusion (6 papers), Pancreatic function and diabetes (5 papers) and Prenatal Substance Exposure Effects (4 papers). The work is most often cited by research in Clinical Biochemistry (1.9k citations), Endocrinology, Diabetes and Metabolism (1.4k citations), Cell Biology (1.3k citations), Physiology (1.8k citations) and Biochemistry (367 citations). Peter J. Oates has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include David A. Beebe, Takeshi Nishikawa, Takeshi Matsumura, Michael Brownlee, Ida Giardino, Diane Edelstein, Yasufumi Kaneda, Mark A. Yorek, Xue Liang Du and Sho‐ichi Yamagishi. Their work appears in journals such as Diabetes, Journal of Medicinal Chemistry, The FASEB Journal, The Journal of Cell Biology and American Journal of Physiology-Heart and Circulatory Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Peter J. Oates

Impact in

Papers in i

In The Last Decade

Peter J. Oates

Peter J. Oates's Hit Papers

Peers

Countries citing papers authored by Peter J. Oates

Fields of papers citing papers by Peter J. Oates

All Works

About Peter J. Oates

Explore authors with similar magnitude of impact

Papers in